GSK

Novartis and GSK Announce Collaboration to Support Scientific Research Into Genetic Diversity in Africa

Summary: 
  • Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients
  • Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years

  • Researchers based at universities, science councils and other public research organizations across Africa are invited to express ‘intent to submit’ by  March 1, 2021

Press Release
  • Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients
  • Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years

  • Researchers based at universities, science councils and other public research organizations across Africa are invited to express ‘intent to submit’ by  March 1, 2021

Meeting the Moment for Healthcare: Q&A With Phil Thomson, President, Global Affairs, GSK

Article

By: Phil Thomson, President, Global Affairs, GSK

Undeniably, 2020 has been defined by the global spread of COVID-19 and its devastating impacts. The global pandemic, which has taken over a million lives, has shone a spotlight on the healthcare industry.

Hear from BP, GSK, and Pernod Ricard at BSR20

Newsletter

The BSR20 Lineup Grows with these Powerful Speakers

BSR's plenary lineup is growing and will cover some of today’s most talked about issues: from preparing for the next pandemic to purpose-based budgeting.

Bernard Looney

CEO, bp

At 3M, Strong Leaders Rise From Heat Experiences

Pro Bono Experiences Catalyze Vertical Talent Development
Article

Heat forms, forges, and strengthens that which it does not burn—it’s the ultimate metaphor for an effective form of leadership development. Similarly, manufactured heat experiences that draw employees out of their comfort zone can increase their ability to absorb information, react quickly and decisively, and thrive in increasingly complex global environments.

8th Global Pro Bono State of the Practice Report Is Released

Press Release

June 12, 2019 /3BL Media/ —The 8thGlobal Pro Bono State of the Practice, presented by PYXERA Global, highlights the top five trends based on data collected from 26 companies, 63 percent of which belong to Fortune’s Global 500.

Faces of GSK's Pro Bono Efforts

How employees create positive change through volunteering
Blog

As the Vice President and Director of Scientific and Public Health for GSK’s Vaccines practice, Dr. Len Friedland has a very rewarding job, but his sense of purpose extends beyond his day job to support people in poor health as well as those with limited access to quality healthcare, as a volunteer. “Helping patients feel better and live longer aren’t just words to me—they’re part of who I am. The way I see it, having great science at the company is fantastic, but it means nothing unless we make sure this science benefits the right people,” said Len.

Pro Bono as a People Strategy in Action: GSK

How GSK creates shared value between CSR and HR
Blog

Taproot has long made the case that a strong corporate pro bono program is a triple win—nonprofits receive the support they need, companies build deeper relationships with their communities, and employees have the opportunity to apply their skills in new and meaningful ways. While there is a robust foundation of evidence supporting the claim that pro bono is a powerful social impact strategy, practitioners often struggle to articulate the business case for pro bono.

New Resource: Pro Bono As a People Strategy

How companies can create shared value between CSR and HR
Article

Taproot has long made the case that a strong corporate pro bono program is a triple win—nonprofits receive the support they need, companies build deeper relationships with their communities, and employees have the opportunity to apply their skills in new and meaningful ways. While a good deal of evidence supports pro bono as a powerful social impact strategy, practitioners often struggle to articulate the business case for pro bono.

GSK Publishes Annual Report and Responsible Business Supplement 2017

Article

“Our company has an important purpose, to help people do more, feel better, live longer. We have a long history in tackling some of the world’s biggest health challenges. I know this is important to employees, and it was certainly important for me when I joined the company. Our commitment to improving global health and being a responsible business will continue under my leadership.

A $40,000 GSK IMPACT Award Can Go A Long Way for A Local Nonprofit

Registration open until March 30, 2018.
Multimedia with summary

GSK is proud to call Durham, NC and Philadelphia, PA regions our home. We are committed to making the communities where we live and work healthier, which is why we have supported local nonprofit organizations with more than $10 million dollars in GSK IMPACT Awards over the past 22 years.

This annual awards program recognizes local nonprofits that are breaking down health barriers in communities across the Philly and Triangle, NC region. Our call for applications for the 2018 GSK IMPACT Awards is open now.

Pages

Subscribe to GSK